Insulin lispro mix 25/75 twice daily (LM25) vs basal insulin glargine once daily and prandial insulin lispro once daily (BP) in type 2 diabetes: insulin intensification

被引：0
|
作者：
Tinahones, F. J. [1 ]
Gross, J. L. [2 ]
Onaca, A.
Zhou, Z. [3 ,4 ]
Cleall, S. [5 ]
Rodriguez, A. [6 ]
机构：
[1] Hosp Univ Virgen de la Victoria, Malaga, Spain
[2] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil
[3] Second Xiangya Hosp, Ctr Diabet, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China
[4] Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China
[5] Eli Lilly & Co, Windlesham, Surrey, England
[6] Lilly Spain, Alcobendas, Spain
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1025
引用
收藏
页码：S412 / S412
页数：1
相关论文
共 50 条
  • [21] Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25 or twice daily human insulin mix 30/70
    Li Yan
    Li Qiang
    Li Cheng-jiang
    Wang Chang-jiang
    Zheng Yi-man
    Issa, Maher
    Zhang Jia
    CHINESE MEDICAL JOURNAL, 2009, 122 (21) : 2540 - 2546
  • [22] Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes A randomized open parallel multicenter study
    Bolli, Geremia B.
    Kerr, David
    Thomas, Reena
    Torlone, Elisabetta
    Sola-Gazagnes, Agnes
    Vitacolonna, Ester
    Selam, Jean Louis
    Home, Philip D.
    DIABETES CARE, 2009, 32 (07) : 1170 - 1176
  • [23] The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) Trial Comparing the durability of lispro mix 75/25 and glargine
    Buse, John B.
    Wolffenbuttel, Bruce H. R.
    Herman, William H.
    Hippler, Stephen
    Martin, Sherry A.
    Jiang, Honghua H.
    Shenouda, Sylvia K.
    Fahrbach, Jessie L.
    DIABETES CARE, 2011, 34 (02) : 249 - 255
  • [24] Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes
    Jovanovic, Lois
    Peters, Anne L.
    Jiang, Honghua H.
    Hardin, Dana S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2014, 26 (02) : 115 - 121
  • [25] Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes
    Lois Jovanovič
    Anne L. Peters
    Honghua H. Jiang
    Dana S. Hardin
    Aging Clinical and Experimental Research, 2014, 26 : 115 - 121
  • [26] Is twice-daily insulin glargine superior to once-daily administration?
    Burge, MR
    Schroeder, E
    DIABETES, 2004, 53 : A120 - A120
  • [27] Equivalence of once-daily and twice-daily insulin glargine administration
    Burge, MR
    Schroeder, E
    DIABETOLOGIA, 2004, 47 : A305 - A305
  • [28] Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times
    Ashwell, SG
    Gebbie, J
    Home, PD
    DIABETIC MEDICINE, 2006, 23 (01) : 46 - 52
  • [29] Optimal timing of injection of once-daily insulin glargine in people with type 1 diabetes using insulin lispro at meal-times
    Ashwell, SG
    Home, PD
    DIABETES, 2004, 53 : A118 - A118
  • [30] Once daily insulin glargine may induce loss of basal insulin action in some patients with type 1 diabetes receiving basal bolus regimens: The need for twice daily glargine?
    Idampitiya, C
    Ward, K
    Curtis, C
    Fernando, DJS
    Idris, I
    Thomson, G
    DIABETES, 2005, 54 : A493 - A493
12345